William Guerrant
Impact in
- Organic Chemistry top 10%
- Click Chemistry and Applications
- Synthesis and biological activity
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Cancer therapeutics and mechanisms
- Chemical Synthesis and Analysis
Papers in
-
- Histone Deacetylase Inhibitors Research 8
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 2
-
- Click Chemistry and Applications 3
- Co-authors
- Adegboyega K. Oyelere (8 shared papers)Vishal Patil (6 shared papers)Joshua C. Canzoneri (2 shared papers)Joseph L. Kissil (3 shared papers)Po C. Chen (4 shared papers)Sandra C. Mwakwari (4 shared papers)Susana Moleirinho (1 shared paper)Shabana I. Khan (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry (2 papers)Cancer Research (2 papers)Current Topics in Medicinal Chemistry (1 paper)FEBS Letters (1 paper)
- Partner nations
- United States
In The Last Decade
William Guerrant
12 papers receiving 711 citations
Peers
Comparison fields: 5 of 63
- Organic Chemistry 227
- Molecular Biology 540
- Cell Biology 107
- Oncology 156
- Toxicology 14
Countries citing papers authored by William Guerrant
This map shows the geographic impact of William Guerrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Guerrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Guerrant more than expected).
Fields of papers citing papers by William Guerrant
This network shows the impact of papers produced by William Guerrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Guerrant. The network helps show where William Guerrant may publish in the future.
Co-authors
The 25 scholars most cited alongside William Guerrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 122 | |
| 2 | 2014 | 92 | |
| 3 | 2008 | 85 | |
| 4 | 2009 | 77 | |
| 5 | 2010 | 76 | |
| 6 | 2010 | 57 | |
| 7 | 2008 | 57 | |
| 8 | 2013 | 52 | |
| 9 | 2016 | 48 | |
| 10 | 2021 | 22 | |
| 11 | 2018 | 16 | |
| 12 | 2010 | 14 |
About William Guerrant
William Guerrant is a scholar working on Molecular Biology, Organic Chemistry, Cell Biology, Infectious Diseases and Oncology, having authored 12 papers that have together received 718 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (4 papers), Click Chemistry and Applications (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Research on Leishmaniasis Studies (2 papers), HIV/AIDS drug development and treatment (2 papers), Ubiquitin and proteasome pathways (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Organic Chemistry (227 citations), Molecular Biology (540 citations), Cell Biology (107 citations), Oncology (156 citations) and Toxicology (14 citations). William Guerrant has collaborated with scholars based in United States. Frequent co-authors include Adegboyega K. Oyelere, Vishal Patil, Joshua C. Canzoneri, Joseph L. Kissil, Po C. Chen, Sandra C. Mwakwari, Susana Moleirinho, Shabana I. Khan, Rebecca L. Hood and Berkley E. Gryder. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Cancer Research, Current Topics in Medicinal Chemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.